Alice Metais

Rennes, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 81 publications

Immunohistochemistry as a tool for identifying PDGFRA amplification in central nervous system tumors.

Immunohistochemistry as a tool for identifying PDGFRA amplification in central nervous system tumors.

Journal: Brain pathology (Zurich, Switzerland)

Published: July 11, 2026

Tectal glioma versus pilocytic astrocytoma: revisiting tumor classification in light of molecular heterogeneity.

Tectal glioma versus pilocytic astrocytoma: revisiting tumor classification in light of molecular heterogeneity.

Journal: Acta neuropathologica

Published: June 20, 2026

Desmoplastic myxoid tumor, SMARCB1-mutant: a case with late recurrence after long-term follow-up.

Desmoplastic myxoid tumor, SMARCB1-mutant: a case with late recurrence after long-term follow-up.

Journal: Free neuropathology

Published: June 06, 2026

Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma.

Glioneuronal Tumour With Neurocytic Differentiation (GNTN): a Molecularly Defined Tumour Type Formerly Referred to as Extraventricular Neurocytoma.

Journal: Neuropathology and applied neurobiology

Published: April 20, 2026

Ovarian central nervous system-type tumors: integrated neuropathological and methylation-based classification reveals site-related features.

Ovarian central nervous system-type tumors: integrated neuropathological and methylation-based classification reveals site-related features.

Journal: Acta neuropathologica communications

Published: February 22, 2026

New Observations on a Low-Grade Diffusely Infiltrative Tumour, SMARCB1 Mutant, Arguing for a New Tumour Type.

New Observations on a Low-Grade Diffusely Infiltrative Tumour, SMARCB1 Mutant, Arguing for a New Tumour Type.

Journal: Neuropathology and applied neurobiology

Published: January 29, 2026

H3K27ME3 loss in diffuse midline gliomas lacking H3K27M or EZHIP expressions, a potential diagnostic pitfall!

H3K27ME3 loss in diffuse midline gliomas lacking H3K27M or EZHIP expressions, a potential diagnostic pitfall!

Journal: Acta neuropathologica

Published: December 23, 2025

Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered.

Usefulness OF SOX10 immunohistochemistry for subtyping diffuse midline gliomas EGFR-altered.

Journal: Acta neuropathologica communications

Published: November 15, 2025

Pineal alveolar rhabdomyosarcoma with PAX3 fusion: A specific clinico-radio-histomolecular type in the CNS.

Pineal alveolar rhabdomyosarcoma with PAX3 fusion: A specific clinico-radio-histomolecular type in the CNS.

Journal: Journal of neuropathology and experimental neurology

Published: October 09, 2025

Extracranial teratoid medulloepithelioma: A pelvic observation with genetic and epigenetic findings.

Extracranial teratoid medulloepithelioma: A pelvic observation with genetic and epigenetic findings.

Journal: Virchows Archiv : an international journal of pathology

Published: October 02, 2025

Immunohistochemistry as a tool for identifying EGFR amplification in CNS tumors.

Immunohistochemistry as a tool for identifying EGFR amplification in CNS tumors.

Journal: Brain pathology (Zurich, Switzerland)

Published: October 01, 2025

Architecture and cellular composition of focal cortical dysplasia type II: qualitative review of histological studies.

Architecture and cellular composition of focal cortical dysplasia type II: qualitative review of histological studies.

Journal: Frontiers in cellular neuroscience

Published: September 18, 2025

Showing 1-12 of 81

Last Updated: 09/26/2026